David Wirta
Eye Research Foundation, Inc. · Eye Research Foundation
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name David Wirta as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:34 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT04761705 · Safety and Efficacy Study of JV-GL1 in Patients With Open-Angle Glaucoma or Ocular HypertensionJeniVision, Inc. · suspended · Ocular Hypertension, Open Angle Glaucoma · principal investigator
- Ph2/Ph3NCT04475432 · Safety and Efficacy of TP-03 for the Treatment of Demodex BlepharitisTarsus Pharmaceuticals, Inc. · completed · Blepharitis · principal investigator
- Ph2/Ph3NCT04343287 · Safety and Efficacy of BRM421 for Dry Eye Syndrome TreatmentBRIM Biotechnology Inc. · completed · Dry Eye Syndrome · principal investigator
- Ph1/Ph2NCT04149899 · Safety and IOP-Lowering Effects of WB007Bausch & Lomb Incorporated · completed · Glaucoma, Primary Open Angle, Ocular Hypertension · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:34 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 06:34 UTC. The ranking covers the 200 most relevant of 30 PubMed records, and a shared surname and initials can bring in a namesake. All 30 on PubMed
- Efficacy and Safety of OC-01 (Varenicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease: The ONSET-2 Phase 3 Randomized Trial.Ophthalmology · 202285 citationsRCR 11.6
- NOV03 for Dry Eye Disease Associated with Meibomian Gland Dysfunction: Results of the Randomized Phase 3 GOBI Study.Ophthalmology · 202383 citationsRCR 16.8
- A Clinical Phase II Study to Assess Efficacy, Safety, and Tolerability of Waterfree Cyclosporine Formulation for Treatment of Dry Eye Disease.Ophthalmology · 201977 citationsRCR 6.1
- 65 citationsRCR 6.8
- 57 citationsRCR 6.4
- 51 citationsRCR 5.5
- 49 citationsRCR 6.9
- Safety and Efficacy of AGN-190584 in Individuals With Presbyopia: The GEMINI 1 Phase 3 Randomized Clinical Trial.JAMA Ophthalmol · 202246 citationsRCR 7.5
- 44 citationsRCR 9.0
- Association of Oxymetazoline Hydrochloride, 0.1%, Solution Administration With Visual Field in Acquired Ptosis: A Pooled Analysis of 2 Randomized Clinical Trials.JAMA Ophthalmol · 202034 citationsRCR 4.4